Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
about
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycinThe role of lomefloxacin in the treatment of chronic prostatitis.Ofloxacin compared with chloramphenicol in the management of external ocular infectionAssessment of the effects of combination therapy with ciprofloxacin and fenbufen on the central nervous systems of healthy volunteers by quantitative electroencephalography.Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles.Fluoroquinolone adverse effects and drug interactions.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Quinolone arthropathy--acute toxicity to immature articular cartilage.Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersOfloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms.Hepatobiliary kinetics and excretion of ciprofloxacin.Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation.Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis)Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infectionsInhibition of norfloxacin absorption by dairy products.Sequential antibiotic therapy: Effective cost management and patient care.Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.Ofloxacin penetration into tuberculous pleural effusionSusceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole.Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbitsMultiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteersEffects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin.Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.Toxicity of quinolone antimicrobial agents.Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS.Clinical experience with ofloxacin (DL-8280) in the therapy of various infections.Formulation and In Vitro Evaluation of Ofloxacin Tablets using Natural Gums as Binders.Levofloxacin-induced autoimmune hemolytic anemia.Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
P2860
Q28341927-EB996220-B713-4A47-A982-150BBE7A5692Q32100749-C1890600-345A-4570-989A-8DFD633D6BF2Q33649156-C7660247-AAE6-46C3-9F9D-9A3AB4755042Q33696090-6F102232-FFE9-43A8-96AF-827014426E4CQ33720333-45A0F209-81D4-4A2E-88CB-A814C2ACB641Q33863671-F6A4CF1C-9B41-4A0C-B21D-ED365F4282C4Q34408447-4D4B8B5E-FF4B-4EAF-9791-3DFCE87D468AQ34687048-5DAFF7BE-0BB5-480E-B50F-2BE6E067C4A3Q35209749-C29B8102-64E0-4742-BD5B-A54628E5BBA3Q35245010-852B63EF-8130-46E3-8D1D-A0C2DEFB1EE8Q35245897-DFF6E414-CE28-4262-87B4-61C8E4210DF7Q35248092-D54BB1A1-ECFD-4C8E-B5FA-A2B294159525Q35270414-235095E6-9DF6-409F-B2A2-D92F6E190351Q35312303-5C04FE96-69E5-4C0F-BB30-719EBD2538FBQ35353352-2518BCBD-5615-493E-B1A8-111614872EB1Q35353461-7968F194-4320-4D44-B5D7-9B4908D86218Q35354313-017FC7B4-0AB2-4C3D-B726-21CDD8A8ABBFQ35564524-36BAC19B-6762-4303-BE43-F7BE120BAC6AQ35565262-B8FDCE1C-1198-4193-98D8-285995D40457Q35615229-1823704A-1A7F-4617-9A6C-0765590A3E18Q35820813-DAA8E5F1-ACE3-4A86-A77C-ECD719430C48Q35826555-76CC435C-FC6B-4B4E-A52A-256EDAF3ADCCQ35893020-69AA675A-B14D-4E58-9609-60414563B38CQ35893937-ACF234EF-0265-422E-9EF3-A8709EE5B139Q36756244-9E7EC58E-9D26-4708-A3A0-5FBDB78C8CB7Q36757313-5D9D3761-B0EF-4368-95B0-2B20D6351173Q37299512-3F8A0A15-3F53-4FB5-8D0B-8F2258414731Q38906775-26AE7C0C-29E7-41DF-8CC1-B89628FF00ADQ39779239-D6E07DE5-5714-41DD-9AB5-9D494D4BD127Q39816080-665E7042-E96E-4A5D-AFA8-01C3C9D505F9Q39817401-5D9CCA3F-3792-45AC-8F5E-7038CF5AFB89Q39832593-8CEF9931-C260-401E-A8C6-20C5F12DF5D3Q39865625-80F15451-7006-4F96-A5FA-8AAB6F1C2255Q39867874-C4DC898D-7AE8-4A14-BA31-4872CB617344Q40526656-60C2AA56-4FF6-46B2-B2D7-8B5FAA921261Q40667645-44DE2F0F-A88B-48F8-A764-A0C107D3CA0DQ40776279-DE155395-E284-4847-96F9-660736388613Q40941326-A8082D2F-D92F-4D06-AABE-6530439273BFQ42166106-4AA27EEB-A69E-45BD-8289-B440DF865FA1Q43762374-07FA2863-1A24-4A17-BDC9-9BEBE703972F
P2860
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Ofloxacin. A review of its ant ...... roperties and therapeutic use.
@en
Ofloxacin. A review of its ant ...... roperties and therapeutic use.
@nl
type
label
Ofloxacin. A review of its ant ...... roperties and therapeutic use.
@en
Ofloxacin. A review of its ant ...... roperties and therapeutic use.
@nl
prefLabel
Ofloxacin. A review of its ant ...... roperties and therapeutic use.
@en
Ofloxacin. A review of its ant ...... roperties and therapeutic use.
@nl
P1433
P1476
Ofloxacin. A review of its ant ...... roperties and therapeutic use.
@en
P2093
D M Campoli-Richards
P304
P356
10.2165/00003495-198733040-00003
P577
1987-04-01T00:00:00Z
P6179
1040343572